Alzai Health Corp. (TSXV:ALZI)
Canada · Delayed Price · Currency is CAD 0.4500
-0.0200 (-4.26%)
Jul 3, 2026, 1:04 PM EST
Alzai Health Market Cap
Alzai Health has a market cap or net worth of CAD 28.87 million as of July 6, 2026.
Market Cap
28.87M
Enterprise Value
28.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.45
Market Cap Chart
Since June 9, 2026, Alzai Health's market cap has increased from 26.94M to 28.87M, an increase of 7.14%. That is a compound annual growth rate of 185.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 28.87M | -4.26% |
| Jun 30, 2026 | 30.15M | 4.44% |
| Jun 29, 2026 | 28.87M | -10.00% |
| Jun 25, 2026 | 32.07M | 6.38% |
| Jun 24, 2026 | 30.15M | -6.00% |
| Jun 22, 2026 | 32.07M | 4.17% |
| Jun 19, 2026 | 30.79M | - |
| Jun 16, 2026 | 30.79M | 6.67% |
| Jun 10, 2026 | 28.87M | 7.14% |
| Jun 9, 2026 | 26.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedMira | 45.61M |
| Microbix Biosystems | 41.33M |
| BriaCell Therapeutics | 39.58M |
| Medicenna Therapeutics | 36.46M |
| Defence Therapeutics | 32.97M |
| Resverlogix | 30.95M |
| Quantum BioPharma | 30.39M |
| Thiogenesis Therapeutics | 29.55M |